Target intelligence / Profile preview

Alpha-1A, Alpha-1B, and Alpha-1D adrenergic receptor (α1A-AR, α1B-AR, α1D-AR (or α1A, α1B, α1D))

Target
α1A-AR, α1B-AR, α1D-AR (or α1A, α1B, α1D)
Molecular classification
G protein-coupled receptor (GPCR), Receptor, Seven transmembrane receptor, Class A (Rhodopsin-like) GPCR
01

Overview

Alpha-1A, Alpha-1B, and Alpha-1D adrenergic receptors are members of the G protein-coupled receptor superfamily, encoded by separate genes. They are activated by endogenous catecholamines, primarily norepinephrine and epinephrine, and mediate the majority of sympathetic responses such as smooth muscle contraction, vasoconstriction and regulation of blood pressure. Each subtype has distinct anatomical distributions and physiological roles: - Alpha-1A is prominent in prostate smooth muscle and plays a role in urinary tract function and cognitive processes[1][4]. - Alpha-1B is highly expressed in vascular smooth muscle and involved in arterial blood pressure regulation[2][3]. - Alpha-1D has significant roles in vascular tissues, particularly contributing to blood pressure regulation[3]. Drugs targeting these receptors are used clinically for conditions such as hypertension and benign prostatic hyperplasia. Antagonists for these receptors, particularly α1A-selective agents, reduce smooth muscle tone in the bladder neck and prostate, while antagonists of all subtypes can lower blood pressure. Novel agonists and strategies to develop subtype-selective drugs aim to optimize therapeutic efficacy while minimizing adverse effects[1][2][5][6]. Note: The query provides a combined designation ("Alpha-1A/1B/1D adrenergic receptors"), which accurately refers to the collective family but lacks the specificity required for precise database entries, as each subtype is a distinct protein with unique properties and drug selectivity profiles[3][6].

Other names
Alpha-1 adrenergic receptor subtypesα1 adrenergic receptorsα1A-ARα1B-ARα1D-ARAdrenoceptor alpha 1A/1B/1DAlpha1A/1B/1D-adrenoceptor
02

Mechanism of action

Antagonists: Block receptor-induced vasoconstriction and smooth muscle contraction, leading to vasodilation or muscle relaxation (e.g. in BPH)[1][5] Agonists: Stimulate Gq protein-mediated signaling, activating phospholipase C pathway, increasing inositol trisphosphate (IP₃) and diacylglycerol (DAG), elevating intracellular calcium, leading to smooth muscle contraction and other responses[3][4]

03

Biological functions

Signal transductionSmooth muscle contractionVasoconstrictionRegulation of blood pressureCognitive functionModulation of metabolismNeurotransmission
04

Disease associations

Cardiovascular disease (e.g., hypertension)Benign prostatic hyperplasia (BPH)InflammationNeurological/psychiatric disorders (via effects on cognition and neurotransmission)
05

Safety considerations

Orthostatic hypotension (with antagonists, due to vascular relaxation)Dizziness and syncopeReflex tachycardiaNasal congestionEjaculatory dysfunction (notably with α1A-selective antagonists such as tamsulosin)Drug selectivity (risk of off-target effects on related adrenergic subtypes)
06

Interacting drugs

Prazosin (antagonist)

10 more in the full profile.

07

Biomarkers

There are currently no established clinical biomarkers specific for patient selection or efficacy monitoring for these receptors, though receptor expression may be used in research for certain conditions.

Beyond the preview

Go deeper on Alpha-1A, Alpha-1B, and Alpha-1D adrenergic receptor (α1A-AR, α1B-AR, α1D-AR (or α1A, α1B, α1D)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1A, Alpha-1B, and Alpha-1D adrenergic receptor (α1A-AR, α1B-AR, α1D-AR (or α1A, α1B, α1D)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call